Keyphrases
Mode of Action
100%
Colon Cancer
100%
Pentoxifylline
100%
Tumor Marker
100%
Action-based
100%
Stomatitis
62%
Inflammatory Cytokines
50%
Cytokine Levels
37%
Chemotherapy
37%
Reduced Dose
25%
Weight Loss
25%
Weight Gain
25%
Soluble interleukin-2 Receptor (sIL-2R)
25%
Colon Cancer Patients
25%
In Cancer
12%
Quality of Life
12%
Anti-inflammatory Effect
12%
Interleukin-6
12%
Cancer Progression
12%
Interleukin-1β
12%
Treatment Group
12%
Weight Reduction
12%
Cancer Patients
12%
Beneficial Effects
12%
Interleukin-8
12%
Anti-tumor Necrosis Factor (anti-TNF)
12%
Clinical Parameters
12%
Metastatic Colorectal Cancer (mCRC)
12%
Cachexia
12%
Blood Analysis
12%
R-2R
12%
Inflammatory Tumor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cytokine
100%
Colon Cancer
100%
Pentoxifylline
100%
Tumor Marker
100%
Stomatitis
62%
Tumor Necrosis Factor
37%
Chemotherapy
37%
Malignant Neoplasm
12%
Antiinflammatory Activity
12%
Cancer Growth
12%
Carcinoembryonic Antigen
12%
Metastatic Colon Cancer
12%
Cachexia
12%
Immunology and Microbiology
Colon
100%
Cytokine
100%
Pentoxifylline
100%
Stomatitis
62%
Inflammatory Cytokine
50%
Tumor Necrosis Factor
37%
Antiinflammatory Activity
12%
Interleukin-6
12%
Interleukin-1
12%
Carcinoembryonic Antigen
12%